Literature DB >> 4136785

Homozygous hypercholesteraemia and the portacaval shunt. The need for a concerted attack by surgeons and clinical researchers.

E H Ahrens.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4136785     DOI： 10.1016/s0140-6736(74)91828-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Portal diversion. Treatment for glycogen storage disease and hyperlipemia.

Authors:  T E Starzl; C W Putnam
Journal:  JAMA       Date:  1975-09-01       Impact factor: 56.272

2.  Portacaval shunt and hyperlipidemia.

Authors:  T E Starzl; C W Putnam; L J Koep
Journal:  Arch Surg       Date:  1978-01

3.  The effect of portacaval shunt upon hepatic cholesterol synthesis and cyclic AMP in dogs and baboons.

Authors:  A Francavilla; A F Jones; J Benichou; T E Starzl
Journal:  J Surg Res       Date:  1980-01       Impact factor: 2.192

4.  Prevention of induced atherosclerosis by diversion of bile or blockade of intestinal lymphatics in dogs.

Authors:  P J Wilk; R C Karipineni; D Pertsemlidis; C A Danese
Journal:  Ann Surg       Date:  1976-04       Impact factor: 12.969

5.  The influence of portal blood upon lipid metabolism in normal and diabetic dogs and baboons.

Authors:  T E Starzl; I Y Lee; K A Porter; C W Putnam
Journal:  Surg Gynecol Obstet       Date:  1975-03

6.  Hypercholesterolaemia type II: changes in plasma insulin and glucagon levels after portacaval shunt.

Authors:  J P Farriaux; A S Luyckx; M Ribet
Journal:  J Inherit Metab Dis       Date:  1980       Impact factor: 4.982
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.